EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LC–MS/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation

Jonathan C Y Tang, John J Dutton, Isabelle Piec, Darrell Green, Emily Fisher, Christopher J Washbourne, William D Fraser

Clinical Mass Spectrometry · 2016

DOI: 10.1016/j.clinms.2016.08.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Mass Spectrometry, 2016. Verfasst von Jonathan C Y Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioanalytical Facility, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pyridinium cross-links pyridinoline (PYD) and deoxypyridinoline (DPD) are established markers of collagen degradation. Measurement of PYD and DPD can be used to evaluate changes in bone turnover in patients with metabolic bone disease and to monitor response to anti-resorptive treatment.

Objective

To develop a method to extract and measure urine free PYD (fPYD) and free DPD (fDPD) by liquid chromatography tandem mass spectrometry (LC-MS/MS). The method was used to quantify urine samples from 172 healthy individuals and 63 patients diagnosed with metabolic bone disease.

Method

Acidified urine samples were extracted using solid phase extraction with cellulose slurry. PYD and DPD were separated by reversed-phase, ion-paired chromatography prior to MS/MS detection.

Results

The fully validated method showed good agreement with other laboratories in the UK National External Proficiency Scheme (UK NEQAS). The method was compared against two commercial immunoassays for fDPD and pyridinium cross-links, r 2 were 0.906 and 0.816 respectively. Urine concentrations of fDPD/Cr and fPYD/Cr were significantly higher in the patients than healthy individuals (p < 0.001). An average (±SD) fDPD:fPYD ratio of 0.29 (±0.08) was consistently observed across all subgroups. A markedly increased fDPD:fPYD ratio of 8.9 was observed in a patient with type VI Ehlers-Danlos Syndrome (EDS).

Conclusion

Simultaneous measurement of two free pyridinium cross-links provides a valuable, cost effective assessment tool for use in the diagnostic work-up of patients with metabolic bone disease. Improvements in sample extraction efficiency have increased assay specificity and analysis throughput. The use of the fDPD:fPYD ratio can assist in the diagnosis of type VI EDS.

Autor:innen und Institutionen

  • Bioanalytical Facility, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK.
  • Department of Diabetes and Endocrinology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich NR4 7UY, UK.
  • Department of Laboratory Medicine, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich NR4 7UY, UK.

Zitieren

APA

Tang, J. C. Y., Dutton, J. J., Piec, I., Green, D., Fisher, E., Washbourne, C. J., & Fraser, W. D. (2016). LC–MS/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation. Clinical Mass Spectrometry. https://doi.org/10.1016/j.clinms.2016.08.001

Vancouver

Tang JCY, Dutton JJ, Piec I, Green D, Fisher E, Washbourne CJ, et al. LC–MS/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation. Clinical Mass Spectrometry. 2016. doi:10.1016/j.clinms.2016.08.001

BibTeX
@article{Tang2016,
  author = {Tang, Jonathan C Y and Dutton, John J and Piec, Isabelle and Green, Darrell and Fisher, Emily and Washbourne, Christopher J and Fraser, William D},
  title = {LC–MS/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation},
  journal = {Clinical Mass Spectrometry},
  year = {2016},
  doi = {10.1016/j.clinms.2016.08.001}
}
Kostenlos starten →